口腔鳞状细胞癌及潜在恶性疾患早期检测的活证据指南:唾液辅助检测决定活检需求(2026版1.0)
该活证据指南评估美国市售唾液辅助检测,用于筛查无黏膜异常的成人及判断口腔或唇黏膜异常成人是否需活检。面板基于活系统评价、范围综述及GRADE EtD框架,发布2条仅限研究使用的推荐和3条良好实践声明,强调临床口腔检查与活检参考标准。
要点
- 所有成人患者均应接受临床口腔检查。
- 持续口腔黏膜异常应活检或转诊,活检为确诊参考标准。
- 唾液辅助检测目前仅限研究场景,不用于常规临床或公共卫生筛查。
核心结论
- 唾液辅助检测用于早期口腔癌检测应仅限于研究场景,不推荐常规临床或公共卫生筛查使用。
研究设计与样本
- 采用活系统评价方法识别唾液辅助检测利弊证据,并对患者与临床医生价值观偏好进行范围综述,同时评估成本、公平性、可接受性和可行性等背景因素。
- 指南面板应用GRADE证据到决策框架制定推荐。
主要发现
- 面板发布2条仅限研究使用的推荐:1条针对有口腔黏膜或唇异常的成人,1条针对无黏膜异常的成人。
- 制定3条良好实践声明:2条推荐对所有成人患者进行临床口腔检查,1条推荐对有持续口腔黏膜异常的成人进行活检或转诊。
关键数值与推荐
- 2条推荐均为研究-only,限制唾液辅助检测用于早期口腔癌检测的研究场景。
- 3条良好实践声明中,2条推荐所有成人患者接受临床口腔检查,1条推荐持续口腔黏膜异常者活检或转诊。
临床怎么用
- 所有成人患者应接受临床口腔检查。
- 发现黏膜异常时,活检仍是确立 definitive 诊断的参考标准。
- 唾液诊断辅助检测无论用于筛查无症状成人还是判断黏膜异常成人是否需要活检,均不应在常规临床实践或公共卫生筛查中使用。
局限性
- 需进一步研究确立唾液辅助检测在临床实践中的潜在作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Major breakthroughs in the clinical application of liquid biopsies, such as the use of salivary samples to detect biomarkers for the early detection of diseases and conditions, are on the horizon. Historically, late detection of oral cancer has contributed to high morbidity and mortality, making scientific advancements in this field particularly impactful. This guideline evaluates and provides recommendations for commercially available salivary adjunct tests in the United States designed specifically for screening adults without mucosal abnormalities and for determining the need for biopsy among adults with mucosal abnormalities of the oral cavity or lip. TYPES OF STUDIES REVIEWED: The researchers used living systematic review methodology to identify evidence on the benefits and harms of salivary adjunct tests. They also conducted a scoping review of patient and clinician values and preferences regarding the use of these adjuncts and evaluated data on other contextual factors, including costs, equity, acceptability, and feasibility of these tests. The guideline panel formulated a recommendation after applying the Grading of Recommendations Assessment, Development and Evaluation Evidence to Decision framework. RESULTS: The panel issued 2 research-only recommendations, limiting the use of salivary adjunct tests for early oral cancer detection to research settings: 1 for adults with oral mucosal or lip abnormalities, and 1 for adults without mucosal abnormalities. Three good practice statements were also formulated: 2 recommending the performance of clinical oral examinations for all adult patients, and 1 recommending biopsy or referral for adult patients with persistent oral mucosal abnormalities. PRACTICAL IMPLICATIONS: All adult patients should receive a clinical oral examination. When a mucosal abnormality is identified, biopsy remains the reference standard for establishing a definitive diagnosis. Salivary diagnostic adjuncts, whether used to screen asymptomatic adults or to determine the need for biopsy in adults with mucosal abnormalities, should not be used in regular clinical practice or as a public health screening measure outside of a research setting. Further research is needed to establish the potential role of salivary adjunct tests in clinical practice.
引用
- Verdugo-Paiva F, Urquhart O, Bhosale AS, et al. Living evidence-informed guideline on the early detection of oral squamous cell carcinoma and potentially malignant disorders: Salivary adjunct tests to determine the need for biopsy, Version 2026 1.0. J Am Dent Assoc. 2026. PMID: 42803738. doi:10.1016/j.adaj.2026.07.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。